Recap: Teladoc Health Q4 Earnings
Portfolio Pulse from Benzinga Insights
Teladoc Health (NYSE:TDOC) reported Q4 earnings with a 19.05% beat on estimated EPS, reporting an EPS of $-0.17 versus an estimate of $-0.21. Revenue increased by $22.82 million from the same period last year. Despite beating last quarter's EPS estimate, the share price dropped by 3.92% the next day. The company has shown a consistent pattern of beating EPS estimates over the past year.
February 20, 2024 | 9:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Teladoc Health reported a significant beat on Q4 earnings estimates and an increase in revenue compared to last year. However, past performance shows a drop in share price following earnings beat.
Despite the positive earnings beat and revenue increase, historical data indicates that Teladoc Health's share price may experience a short-term drop following the earnings announcement, as seen in the last quarter. The pattern of beating EPS estimates but experiencing a share price drop the following day suggests investor reactions may not align with the earnings outcomes.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100